Like n comment pls-To The Moon - Tiger Brokers Online Investing Community - To The Moon

8
4
Favorite

Jarvis92
2021-07-08

Like n comment pls

Keymed Makes Hong Kong Debut, Raises $378 million

Investing.com – Keymed Biosciences Inc. (HK:2162) made its debut on the Hong Kong Stock Exchange and

Keymed Makes Hong Kong Debut, Raises $378 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

8

Report

Comment（4）

Top
Latest

EriViL
·2021-07-08
Like pla
Reply
Like
Report
Fold Replies
- miaomee:
  Like and comment pls
  2021-07-08
  Reply
  Report
猫山王77
·2021-07-08
Done. Like n comment back pls. ?
Reply
1
Report
Fold Replies
- nonwoke:
  okay
  2021-07-08
  Reply
  Report

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":149788377,"tweetId":"149788377","gmtCreate":1625748848599,"gmtModify":1703747709624,"author":{"id":4087992674383480,"idStr":"4087992674383480","authorId":4087992674383480,"authorIdStr":"4087992674383480","name":"Jarvis92","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Like n comment pls</p></body></html>","htmlText":"<html><head></head><body><p>Like n comment pls</p></body></html>","text":"Like n comment pls","highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":4,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/149788377","repostId":1169240809,"repostType":4,"repost":{"id":"1169240809","kind":"news","pubTimestamp":1625748735,"share":"https://www.laohu8.com/m/news/1169240809?lang=&edition=full","pubTime":"2021-07-08 20:52","market":"hk","language":"en","title":"Keymed Makes Hong Kong Debut, Raises $378 million","url":"https://stock-news.laohu8.com/highlight/detail?id=1169240809","media":"Investing.com","summary":"Investing.com – Keymed Biosciences Inc. (HK:2162) made its debut on the Hong Kong Stock Exchange and","content":"<p>Investing.com – Keymed Biosciences Inc. (HK:2162) made its debut on the Hong Kong Stock Exchange and raised HK$2.94 billion ($378.48 million) in the process.</p>\n<p>Keymed’s Hong Kong shares were at HK$70 by 1:32 AM ET (5:32 AM GMT), after opening 46.3% higher at $78. The company offered 58.26 million shares priced at HK$53.3 each, the top end of its range of HK$50.5 to HK$53.3.</p>\n<p>Of the more than 20 companies that launched share sales at the end of June 2021, Keymed was one of the most subscribed candidates. Retail investors placed HK$53.2 billion worth of orders, a 171-times oversubscription, for the company’s shares. A total of 15 cornerstone investors also subscribed to HK$1.48 billion worth of shares, or around 50% of the total issued amount.</p>\n<p>The list of investors includes Invesco, UBS Asset Management, Temasek, Hillhouse Capital, Lake Bleu Capital and CSPC Pharmaceutical. The company was also reportedly able to close the institutional books a day earlier than expected.</p>\n<p>Founded in 2016, Chengdu, China-based Keymed develops therapies to treat cancer and autoimmune diseases. It has nine drug candidates that have been approved as investigational new drugs and is running clinical trials for five of them.</p>\n<p>However, with none of the candidates expected to be commercialized before 2023, Keymed has yet to generate profit from product sales. The company’s net loss widened by 3.89 times to CNY818.8 million ($126.49 million) in 2020 as R&amp;D investments and administrative expenses increased.</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Keymed Makes Hong Kong Debut, Raises $378 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKeymed Makes Hong Kong Debut, Raises $378 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-08 20:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/keymed-makes-hong-kong-debut-013433823.html><strong>Investing.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investing.com – Keymed Biosciences Inc. (HK:2162) made its debut on the Hong Kong Stock Exchange and raised HK$2.94 billion ($378.48 million) in the process.\nKeymed’s Hong Kong shares were at HK$70 by...</p>\n\n<a href=\"https://finance.yahoo.com/news/keymed-makes-hong-kong-debut-013433823.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"02162":"康诺亚-B"},"source_url":"https://finance.yahoo.com/news/keymed-makes-hong-kong-debut-013433823.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1169240809","content_text":"Investing.com – Keymed Biosciences Inc. (HK:2162) made its debut on the Hong Kong Stock Exchange and raised HK$2.94 billion ($378.48 million) in the process.\nKeymed’s Hong Kong shares were at HK$70 by 1:32 AM ET (5:32 AM GMT), after opening 46.3% higher at $78. The company offered 58.26 million shares priced at HK$53.3 each, the top end of its range of HK$50.5 to HK$53.3.\nOf the more than 20 companies that launched share sales at the end of June 2021, Keymed was one of the most subscribed candidates. Retail investors placed HK$53.2 billion worth of orders, a 171-times oversubscription, for the company’s shares. A total of 15 cornerstone investors also subscribed to HK$1.48 billion worth of shares, or around 50% of the total issued amount.\nThe list of investors includes Invesco, UBS Asset Management, Temasek, Hillhouse Capital, Lake Bleu Capital and CSPC Pharmaceutical. The company was also reportedly able to close the institutional books a day earlier than expected.\nFounded in 2016, Chengdu, China-based Keymed develops therapies to treat cancer and autoimmune diseases. It has nine drug candidates that have been approved as investigational new drugs and is running clinical trials for five of them.\nHowever, with none of the candidates expected to be commercialized before 2023, Keymed has yet to generate profit from product sales. The company’s net loss widened by 3.89 times to CNY818.8 million ($126.49 million) in 2020 as R&D investments and administrative expenses increased.","news_type":1},"isVote":1,"tweetType":1,"viewCount":351,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":15,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":5161395,"commentId":"5161395","gmtCreate":1625749043111,"gmtModify":1663230709129,"authorId":3577087216911488,"author":{"id":3577087216911488,"idStr":"3577087216911488","authorId":3577087216911488,"name":"EriViL","avatar":"https://static.tigerbbs.com/f37d027290c1cdf3fa6cdba6443077c6","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":149788377,"objectIdStr":"149788377","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Like pla","text":"Like pla","html":"Like pla","likeSize":0,"commentSize":1,"subComments":[{"id":5161609,"commentId":"5161609","gmtCreate":1625750429040,"gmtModify":1663230709631,"authorId":3569375896365334,"author":{"id":3569375896365334,"idStr":"3569375896365334","authorId":3569375896365334,"name":"miaomee","avatar":"https://static.tigerbbs.com/fd309d5a46384576888494b61b0e5953","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":149788377,"objectIdStr":"149788377","type":1,"supId":5161395,"supIdStr":"5161395","prevId":0,"prevIdStr":"0","content":"Like and comment <u>pls</u>","text":"Like and comment <u>pls</u>","html":"Like and comment <u>pls</u>"}],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0},{"id":5161386,"commentId":"5161386","gmtCreate":1625748956872,"gmtModify":1635234137992,"authorId":3567656189229002,"author":{"id":3567656189229002,"idStr":"3567656189229002","authorId":3567656189229002,"name":"猫山王77","avatar":"https://static.tigerbbs.com/b0f449741d66eb9e2e9d062335702513","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":149788377,"objectIdStr":"149788377","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Done. Like n comment back pls. ?","text":"Done. Like n comment back pls. ?","html":"Done. Like n comment back pls. ?","likeSize":1,"commentSize":1,"subComments":[{"id":5161398,"commentId":"5161398","gmtCreate":1625749055343,"gmtModify":1663230712647,"authorId":3563442467729531,"author":{"id":3563442467729531,"idStr":"3563442467729531","authorId":3563442467729531,"name":"nonwoke","avatar":"https://static.tigerbbs.com/73e577625d645cfa3ebb543fecfcb19a","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":149788377,"objectIdStr":"149788377","type":1,"supId":5161386,"supIdStr":"5161386","prevId":0,"prevIdStr":"0","content":"<u>okay</u>","text":"<u>okay</u>","html":"<u>okay</u>"}],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0}],"hasMoreComment":true,"orderType":2}